1. H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications

   • Victor M. Lu
   • Tomas Marek
   • David J. Daniels

   Topic Review 24 July 2019 Pages: 433 - 443

   

2. A systematic review and meta-analysis of outcomes in pediatric, recurrent ependymoma

   • Lennox Byer
   • Cassie N. Kline
   • Sabine Mueller

   Topic Review 09 September 2019 Pages: 445 - 452

   

3. Brain tumor acidification using drugs simultaneously targeting multiple pH regulatory mechanisms

   • Mohammed Albatany
   • Valeriy G. Ostapchenko
   • Robert Bartha

   Laboratory Investigation 07 August 2019 Pages: 453 - 462

   

4. G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis

   • L. F. F. Bittencourt
   • G. L. Negreiros-Lima
   • L. S. Barcelos

   Laboratory Investigation 07 August 2019 Pages: 463 - 473

   

5. Correction to: G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis

   • L. F. F. Bittencourt
   • G. L. Negreiros-Lima
   • L. S. Barcelos

   Correction 02 September 2019 Pages: 475 - 475

6. Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics

   • Vineesh Indira Chandran
   • Charlotte Welinder
   • Mattias Belting

   Laboratory Investigation Open access 14 August 2019 Pages: 477 - 488

   

7. Moderate hypothermia inhibits both proliferation and migration of human glioblastoma cells

   • Clémentine Fulbert
   • Christophe Gaude
   • David Ratel

   Laboratory Investigation 20 August 2019 Pages: 489 - 499

   

8. Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial

   • Sied Kebir
   • Christina Schaub
   • Ulrich Herrlinger

   Clinical Study 19 July 2019 Pages: 501 - 509

   

9. Predicting disease progression in high-grade glioma with neuropsychological parameters: the value of personalized longitudinal assessment

   • Elke Butterbrod
   • Jimme Bruijn
   • Karin Gehring

   Clinical Study Open access 24 July 2019 Pages: 511 - 518

   

10. Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas

    • Yasukazu Fukuya
    • Soko Ikuta
    • Yoshihiro Muragaki

    Clinical Study 30 July 2019 Pages: 519 - 528

    

11. Initial biopsy and early re-resection practices in the treatment of glioblastoma among AANS/CNS tumor section surgeons

    • Rebecca B. Baron
    • Remi A. Kessler
    • Constantinos G. Hadjipanayis

    Clinical Study 31 July 2019 Pages: 529 - 534

    

12. The impact of rural residence on adult brain cancer survival in the United States

    • Arash Delavar
    • Omar M. Al Jammal
    • Martin H. Pham

    Clinical Study 05 August 2019 Pages: 535 - 543

    

13. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform

    • Menha Swellam
    • Lobna Ezz El Arab
    • Samy B. Said

    Clinical Study 17 August 2019 Pages: 545 - 551

    

14. Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation

    • Denise D. Correa
    • Erica Braun
    • Antonio Omuro

    Clinical Study 03 August 2019 Pages: 553 - 562

    

15. Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma

    • Todd W. Miller
    • Nicole A. Traphagen
    • Camilo E. Fadul

    Clinical Study 09 August 2019 Pages: 563 - 572

    

16. Association between tumor location and neurocognitive functioning using tumor localization maps

    • Esther J. J. Habets
    • Eef J. Hendriks
    • Martin Klein

    Clinical Study 13 August 2019 Pages: 573 - 582

    

17. CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases

    • Nicholas B. Figura
    • Thrisha K. Potluri
    • Kamran A. Ahmed

    Clinical Study 09 August 2019 Pages: 583 - 589

    

18. Extent of resection and survival for oligodendroglioma: a U.S. population-based study

    • Connor J. Kinslow
    • Andrew L.A. Garton
    • Tony J. C. Wang

    Clinical Study 12 August 2019 Pages: 591 - 601

    

19. Long-term visual acuity outcomes after radiation therapy for sporadic optic pathway glioma

    • Sahaja Acharya
    • Sophia Quesada
    • Thomas E. Merchant

    Clinical Study 14 August 2019 Pages: 603 - 610